PKM and colorectal carcinoma: Exosomes from oxaliplatin-resistant CRC cells can deliver ciRS-122 to oxaliplatin-sensitive cells, which thereby upregulates PKM2 expression and promotes the glycolysis and drug resistance of CRC cells (81).